Literature DB >> 31452242

Loss of tau and Fyn reduces compensatory effects of MAP2 for tau and reveals a Fyn-independent effect of tau on calcium.

Guanghao Liu1, Ramasamy Thangavel2, Jacob Rysted3, Yohan Kim2, Meghan B Francis2, Eric Adams2, Zhihong Lin3, Rebecca J Taugher4, John A Wemmie4, Yuriy M Usachev3, Gloria Lee2.   

Abstract

Microtubule-associated protein tau associates with Src family tyrosine kinase Fyn and is tyrosine phosphorylated by Fyn. The presence of tyrosine phosphorylated tau in AD and the involvement of Fyn in AD has drawn attention to the tau-Fyn complex. In this study, a tau-Fyn double knockout (DKO) mouse was generated to investigate the role of the complex. DKO mice resembled Fyn KO in novel object recognition and contextual fear conditioning tasks and resembled tau KO mice in the pole test and protection from pentylenetetrazole-induced seizures. In glutamate-induced Ca2+ response, Fyn KO was decreased relative to WT and DKO had a greater reduction relative to Fyn KO, suggesting that tau may have a Fyn-independent role. Since tau KO resembled WT in its Ca2+ response, we investigated whether microtubule-associated protein 2 (MAP2) served to compensate for tau, since the MAP2 level was increased in tau KO but decreased in DKO mice. We found that like tau, MAP2 increased Fyn activity. Moreover, tau KO neurons had increased density of dendritic MAP2-Fyn complexes relative to WT neurons. Therefore, we hypothesize that in the tau KO, the absence of tau would be compensated by MAP2, especially in the dendrites, where tau-Fyn complexes are of critical importance. In the DKO, decreased levels of MAP2 made compensation more difficult, thus revealing the effect of tau in the Ca2+ response.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fyn; MAP2; calcium; proximity ligation assay; tau

Mesh:

Substances:

Year:  2019        PMID: 31452242      PMCID: PMC6850396          DOI: 10.1002/jnr.24517

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  88 in total

1.  Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice.

Authors:  S Ikegami; A Harada; N Hirokawa
Journal:  Neurosci Lett       Date:  2000-02-04       Impact factor: 3.046

2.  Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.

Authors:  Peng Lei; Scott Ayton; David I Finkelstein; Loredana Spoerri; Giuseppe D Ciccotosto; David K Wright; Bruce X W Wong; Paul A Adlard; Robert A Cherny; Linh Q Lam; Blaine R Roberts; Irene Volitakis; Gary F Egan; Catriona A McLean; Roberto Cappai; James A Duce; Ashley I Bush
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

3.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

4.  Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

Authors:  Erik D Roberson; Brian Halabisky; Jong W Yoo; Jinghua Yao; Jeannie Chin; Fengrong Yan; Tiffany Wu; Patricia Hamto; Nino Devidze; Gui-Qiu Yu; Jorge J Palop; Jeffrey L Noebels; Lennart Mucke
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

5.  Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex.

Authors:  Gerard M J Beaudoin; Seung-Hye Lee; Dipika Singh; Yang Yuan; Yu-Gie Ng; Louis F Reichardt; Jyothi Arikkath
Journal:  Nat Protoc       Date:  2012-08-30       Impact factor: 13.491

6.  Altered microtubule organization in small-calibre axons of mice lacking tau protein.

Authors:  A Harada; K Oguchi; S Okabe; J Kuno; S Terada; T Ohshima; R Sato-Yoshitake; Y Takei; T Noda; N Hirokawa
Journal:  Nature       Date:  1994-06-09       Impact factor: 49.962

7.  Age-appropriate cognition and subtle dopamine-independent motor deficits in aged tau knockout mice.

Authors:  Meaghan Morris; Patricia Hamto; Anthony Adame; Nino Devidze; Eliezer Masliah; Lennart Mucke
Journal:  Neurobiol Aging       Date:  2013-01-16       Impact factor: 4.673

8.  Loss of Fyn tyrosine kinase on the C57BL/6 genetic background causes hydrocephalus with defects in oligodendrocyte development.

Authors:  June Goto; Tohru Tezuka; Takanobu Nakazawa; Hiroshi Sagara; Tadashi Yamamoto
Journal:  Mol Cell Neurosci       Date:  2008-03-04       Impact factor: 4.314

9.  Targeting ASIC1a reduces innate fear and alters neuronal activity in the fear circuit.

Authors:  Matthew W Coryell; Adam E Ziemann; Patricia J Westmoreland; Jill M Haenfler; Zlatan Kurjakovic; Xiang-ming Zha; Margaret Price; Mikael K Schnizler; John A Wemmie
Journal:  Biol Psychiatry       Date:  2007-07-30       Impact factor: 13.382

10.  Motor and cognitive deficits in aged tau knockout mice in two background strains.

Authors:  Peng Lei; Scott Ayton; Steve Moon; Qihao Zhang; Irene Volitakis; David I Finkelstein; Ashley I Bush
Journal:  Mol Neurodegener       Date:  2014-08-14       Impact factor: 14.195

View more
  4 in total

1.  Fyn depletion ameliorates tauP301L-induced neuropathology.

Authors:  Guanghao Liu; Kimberly L Fiock; Yona Levites; Todd E Golde; Marco M Hefti; Gloria Lee
Journal:  Acta Neuropathol Commun       Date:  2020-07-14       Impact factor: 7.801

Review 2.  Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease.

Authors:  Sofia Toniolo; Arjune Sen; Masud Husain
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

3.  Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways.

Authors:  Chencen Lai; Zhuyi Chen; Yuanting Ding; Qian Chen; Songbai Su; Heng Liu; Ruiqing Ni; Zhi Tang
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

4.  The evolution of microtubule associated proteins - a reference proteomic perspective.

Authors:  Amy C Gottschalk; Marco M Hefti
Journal:  BMC Genomics       Date:  2022-04-06       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.